Atherosclerotic risk factors and premature atherosclerosis in acromegaly before and after 48 months of octreotide-LAR treatment

Angiology

Volumn 63, Issue 7, 2012, Pages 522-527

  Boysan, S N ^a   Kantarci, F ^a   Celik, O ^a   Mihmanli, I ^a   Gazioglu, N ^a   Kadioglu, Pinar ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

acromegaly; atherosclerosis; insulin like growth factor 1; insulin resistance; octreotide treatment

Indexed keywords

GROWTH HORMONE; LEVOTHYROXINE; OCTREOTIDE; PREDNISOLONE; SEX HORMONE;

ACROMEGALY; ADRENAL DISEASE; ADULT; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; BODY MASS; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DOPPLER ECHOGRAPHY; FEMALE; HOMEOSTASIS MODEL OF ASSESSMENT INSULIN RESISTANCE; HUMAN; HYPOGONADISM; HYPOTHYROIDISM; MALE; PREMATURE ATHEROSCLEROSIS; TREATMENT RESPONSE;

ACROMEGALY; ADULT; CAROTID ARTERY DISEASES; CAROTID ARTERY, INTERNAL; COMBINED MODALITY THERAPY; DELAYED-ACTION PREPARATIONS; ECHOCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMAN GROWTH HORMONE; HUMANS; INSULIN RESISTANCE; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; OCTREOTIDE; TUNICA INTIMA; TUNICA MEDIA; ULTRASONOGRAPHY, DOPPLER;

EID: 84866397457     PISSN: 00033197     EISSN: 19401574     Source Type: Journal    
DOI: 10.1177/0003319711431879     Document Type: Article

References (29)

1. Orme SM, McNally JQ, Cartwright RA, Belchets PE. Mortality and cancer incidence in acromegaly: a retrospective cohort study. J Clin Endocrinol Metab. 1998 ; 83 (8). 2730-2734
2. Colao A, Baldelli R, Marzullo P, et al. Systemic hypertension and impaired glucose tolerance are independently correlated to the severity of the acromegalic cardiomyopathy. J Clin Endocrinol Metab. 2000 ; 85 (1). 193-199
3. Sowers JR, Standley PR, Ram JL, Jacober S, Simpson L, Rose K. Hyperinsulinemia, insulin resistance, and hyperglycemia: contributing factors in the pathogenesis of hypertension and atherosclerosis. Am J Hypertens. 1993 ; 6 (7 pt 2). 260-270
4. Otsuki M, Kasayama S, Yamamoto H, et al. Characterization of premature atherosclerosis of carotid arteries in acromegalic patiens. Clin Endocrinol (Oxf). 2001 ; 54 (6). 791-796
5. Colao A, Spiezia S, Cerbone G, et al. Increased arterial intima media thickness by B-M mode echodopler ultrasonography in acromegaly. Clin Endocrinol. 2001 ; 54 (4). 515-524
6. Colao A, Marzullo P, Lombardi G,. and the Italian Multicenter Study Group on Lantreotide Effect of a six-month treatment with lanreotide on cardiovascular risk factors and arterial intima-media thickness in patients with acromegaly. Eur J Endocrinol. 2002 ; 146 (3). 303-309
7. Giustina A, Barkan A, Casanuea FF, et al. Criteria for cure of acromegaly: a consensus statement. J Clin Endocrinol Metab. 2000 ; 85 (2). 526-529
8. Bastard JP, Grimaldi A, Jardel C, Porquet D, Bruckert E, Hainque B. A simple index of insulin resistance. Diabetes Metab. 1997 ; 23 (1). 87-88
9. Pignoli P, Tremoli E, Poli A, Oreste P, Paoletti R. Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging. Circulation. 1986 ; 74 (6). 1399-1406
10. Tanuguchi A, Fukushima M, Sakai M, et al. The role of body mass index and trigliceride levels in identifying insulin sensitive and insulin variants in Japanese non-insulin dependent diabetic patients. Metabolism. 2000 ; 49 (8). 1001-1005
11. Colao A, Pivonello R, Spiezia S, et al. Persistance of increased cardiovascular risk in patients with Cushing's disease after five years of successful cure. J Clin Endocrinol Metab. 1999 ; 84 (8). 2664-2672
12. Hirai T, Sasayama S, Kawasaki T, Yagi S. Stiffness of systemic arteries in patients with myocardial infarction. Circulation. 1989 ; 80 (1). 78-86
13. Sesmilo G, Fairfield WP, Katznelson K, et al. Cardiovascular risk factors in acromegaly before and after normalization of serum IGF-1 levels with the GH antagonist pegvisomant. J Clin Endocrinol Metab. 2002 ; 87 (4). 1692-1699
14. Krsek M, Prazny M, Marek J, Skhra J, Justova V, Lacinova Z. The relationship between serum levels of insulin like growth factor-1 and its binding proteins and microvascular function in acromegalic patients. Growth Horm IGF Res. 2002 ; 12 (1). 54-59
15. Brevetti G, Marzullo P, Silvestro A, et al. Early vascular alterations in acromegaly. J Clin Endocrinol Metab. 2002 ; 87 (7). 3174-3179
16. Smith JC, Lane H, Davies N, et al. The effects of depot long acting somatostatin analog on central aortic pressure and arterial stiffness in acromegaly. J Clin Endocrinol Metab. 2003 ; 88 (6). 2556-2561
17. Cannavo S, Almoto B, Cavalli G, et al. Acromegaly and coronary disease: an integrated evaluation of conventional coronary risk factors and coronary calcifications detected by computed tomography. J Clin Endocrinol Metab. 2006 ; 91 (10). 3766-3772
18. Berg C, Petersenn S, Lahner H, et al. Cardiovascular risk factors in patients with uncontrolled and long-term acromegaly: comparison with matched data from the general population and the effect of disease control. J Clin Endocrinol Metab. 2010 ; 95 (8). 3648-3656
19. Bogazzi F, Battolla L, Spinelli C, et al. Risk factors for development of coronary heart disease in patients with acromegaly: a five-year prospective study. J Clin Endocrinol Metab. 2007 ; 92 (11). 4271-4277
20. Kartal I, Oflaz H, Pamukçu B, et al. Investigation of early atherosclerotic changes in acromegalic patients. Int J Clin Pract. 2010 ; 64 (1). 39-44
21. Tsukahara H, Gordienko DV, Tonshoff B, Gelato MC, Goligorsky MS. Direct demonstration of insulin-like growth factor-I-induced nitric oxide production by endothelial cells. Kidney Int. 1994 ; 45 (2). 598-604
22. Böger RH, Bode-Böger SM, Mügge A, et al. Supplementation of hypercholesterolaemic rabbits with L-arginine reduces the vascular release of superoxide anions and restores NO production. Atherosclerosis. 1995 ; 117 (2). 273-284
23. Tsao PS, Theilmeier G, Singer AH, Leung LL, Cooke JP. L-arginine attenuates platelet reactivity in hypercholesterolemic rabbits. Arterioscler Thromb. 1994 ; 14 (10). 1529-1533
24. Ronconi V, Giacchetti G, Mariniello B, et al. Reduced nitric oxide levels in acromegaly: cardiovascular implications. Blood Pres. 2005 ; 14 (4). 227-232
25. Salomaa V, Riley W, Karak JD, Nardo C, Folsom A. Non-insulin-dependent diabetes mellitus and fasting glucose and insulin concentration are associated with arterial stiffness indexes. Circulation. 1995 ; 91 (5). 1432-1443
26. Napoli R, Guardosole V, Angelini V, et al. Acute effects of growth hormone on vascular function in human subjects. J Clin Endocrinol Metab. 2003 ; 88 (6). 2817-2820
27. Nolan BP, Senechal P, Waqar S, Myers J, Standley CA, Standley PR. Altered insulin like growth factor 1 and nitric oxide sensitiveness in hypertension contribute to vascular hyperplasia. Am J Hypertens. 2003 ; 16 (5 pt 1). 393-400
28. Janssen JAMJL, Stokl RP, Polps HAP, Grobee DE, Lamberts SWJ. Serum total IGF-1, free IGF-1 and IGFBP-1 levels in elderly population to cardiovascular risk factors and disease. Arterioscler Thromb Vasc Biol. 1998 ; 18 (2). 277-282
29. Clayton RN. Cardiovascular function in acromegaly. Endocr Rev. 2003 ; 24 (3). 272-277